HR7407Referred to Committee

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-02-05
Introduced
0
Cosponsors
HR
ⓘ
Type

Sponsor

Frank Pallone, Jr.
Frank Pallone, Jr.
Democrat · NJ · Representative
Votes with party: 97.9% (605 recorded votes)

Full profile: /officials/P000034

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-02-05

Source: Congress.gov

Plain-English Summary

This bill would ban the sale and distribution of tianeptine, a drug sometimes sold as a dietary supplement or nootropic that can cause addiction and serious health problems, along with other similar dangerous products. The ban would apply to retailers, online sellers, and manufacturers across the country, protecting consumers—especially young people—from accessing these substances that are not approved by the FDA for human consumption. The measure aims to close loopholes that currently allow these drugs to be marketed and sold legally despite their health risks.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.